Papillomavirus and HPV typing

Clinics in Dermatology

Volumn 15, Issue 2, 1997, Pages 199-206

  De Villiers, Ethel Michele ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONDYLOMA; GENE AMPLIFICATION; HEAD AND NECK CANCER; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SKIN CANCER; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS GENOME; VIRUS TYPING; WART VIRUS;

EID: 0030919310     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00164-2     Document Type: Article

References (83)

1. Delius H, Hofmann B. Primer-directed sequencing of human papillomavirus types. Curr Top Microbiol Immunol 1994;86:13-31.
2. Bernard H-U, Chan S-Y, Delius H. Evolution of papillomaviruses. Curr Top Microbiol Immunol 1994;86:33-54.
3. de Villiers E-M. Human pathogenic papillomavirus types: An update. Curr Top Microbiol Immunol 1994;86:1-12.
4. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995;61:13-22.
5. Schneider A, Meinhardt G, Kirchmayer R, et al. Prevalence of human papillomavirus genomes in tissues from the lower genital tract as detected by molecular in situ hybridization. Int J Gynecol Pathol 1991;10:1-14.
6. Durst M, Glitz D, Schneider A, et al. Human papillomavirus 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992;189:132-10.
7. Nuovo GJ, Darfler MM, Impraim CC, et al. Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 1991;138:53-8.
8. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1989;239:487-91.
9. Manos MM, Ting T, Wright DK, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells Mol Diagnost Hum Cancer 1989;7:209-14.
10. van den Brule AJC, Meijer CJLM, Bakels V, et al. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 1990;28: 2739-43.
11. Smits HL, Tieben LM, Tjong-A-Hung SP, et al. Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequence analysis allow the identification of a broad spectrum of human papillomavirus types. J Gen Virol 1992;73:3263-8.
12. Cornelissen MTE, van den Tweel JG, Struyk APHB, et al. Localization of human papillomavirus type 16 DNA using the polymerase chain reaction in the cervix uteri of women with cervical intraepithelial neoplasia. J Gen Virol 1989;70:2555-62.
13. Fujinaga Y, Shimada M, Okazawa K, et al. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991;72:1039-44.
14. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 64. Human papillomaviruses. Lyon: IARC, 1995.
15. Lungu O, Sun XW, Felix J, et al. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA 1992;267:2493-6.
16. Yoshikawa H, Kawana T, Kitagawa K, et al. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991;82:524-31.
17. de Roda-Husman AM, Walboomers JMM, van den Brule AJC, et al. The use of general primers GP5 and GP6 elongated at their 3′ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
18. Ylitalo N, Bergstrom T, Gyllensten U. Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization. J Clin Microbiol 1995;33:1822-8.
19. Zitz JC, McLachlin CM, Tate JE, et al. Restriction fragment length polymorphism analysis of isotope-labeled polymerase chain reaction-amplified human papillomavirus DNA combines sensitivity with built-in contamination detection. Mod Pathol 1994;7:407-11.
20. Jacobs MV, de Roda-Husman AM, van den Brule AJC, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
21. Rady PL, Arany I, Hughes TK, et al. Type-specific primer-mediated direct sequencing of consensus primer-generated PCR amplicons of human papilloma viruses: a new approach for the simultaneous detection of multiple viral type infections. J Virol Methods 1995;53:245-54.
22. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170:1077-85.
23. Ong CK, Bernard HU, Villa LL. Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of Amazonian Indians. J Infect Dis 1994;170:1086-8.
24. Peyton CL, Wheeler CM. Identification of five novel papillomavirus sequences in the new Mexico triethnic population. J Infect Dis 1994;170:1089-92.
25. Peyton CL, Jansen AM, Wheeler CM, et al. A novel human papillomavirus sequence from an international cervical cancer study. J Infect Dis 1994;170:1093-5.
26. Manos MM, Waldman J, Zhang TY, Greer CE, et al. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 1994;170: 1096-9.
27. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
28. Rattray C, Strickler HD, Escoffery C, et al. Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients. J Infect Dis 1996;173:718-21.
29. zur Hausen H. Genital papillomavirus infections. In: Rigby PWJ, Wilkie NM, editors. Viruses and cancer. Cambridge: Cambridge University Press, 1985: 83-90.
30. Lörincz AT, Reid R, Jenson B, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common genital types. Obstet Gynecol 1992;79:328-37.
31. Wheeler CM, Greer CE, Becker TM, et al. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88:261-8.
32. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
33. Tate JE, Resnick M, Sheets EE, et al. Absence of papillomavirus DNA in normal tissue adjacent to most cervical intraepithelial neoplasms. Obstet Gynecol 1996;88:257-60.
34. Longuet M, Beaudenon S, Orth G. Two novel genital human papillomavirus (HPV) types, HPV 68 and HPV 70, related to the potentially oncogenic HPV 39. J Clin Microbiol 1996;34:738-44.
35. Trimble CL, Hildesheim A, Brinton LA, et al. Heterogenous etiology of squamous carcinoma of the vulva. Obstet Gynecol 1996;87:59-64.
36. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochem Biophys Acta, 1996;1288:F55-F78.
37. de Villiers E-M. Importance of human papillomavirus DNA typing in the diagnosis of anogenital warts in children. Arch Dermatol 1995;131:366-7.
38. de Villiers E-M. Papillomaviruses in cancers and papillomas of the aerodigestive tract. Biomed Pharmacother 1989;43:31-6.
39. Beaudenon S, Praetorius F, Kremsdorf D, et al. A new type of human papillomavirus associated with oral focal epithelial hyperplasia. J Invest Dermatol 1987;88:130-5.
40. Greenspan D, de Villiers E-M, Greenspan JS, et al. Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol 1988;17:482-7.
41. Völter C, He Y, Delius H, et al. Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer 1996;66:453-6.
42. de Villiers E-M, Weidauer H, Otto H, et al. Papillomavirus DNA in human tongue carcinomas. Int J Cancer 1985;36: 575-8.
43. Snijders PJF, Scholes AGM, Hart CA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 1996;66: 464-9.
44. Palefsky JM, Silverman S Jr, Abdel-Salaam M, et al. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 1995;24:193-7.
45. Flaitz CM, Nichols CM, Adler-Storthz K, et al. Intraoral squamous cell carcinoma in human immunodeficiency virus infection. A clinicopathological study. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1995;8:55-62.
46. Egawa Inaba Y, Ono T, Arao T. "Cystic papilloma" in humans? Demonstration of human papillomavirus in plantar epidermoid cyst. Arch Dermatol 1990;126:1599-603.
47. Matsukura T, Iwasaki T, Kawashima M. Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes. Virology 1992;190:561-4.
48. Egawa K, Honda Y, Inaba Y, et al. Detection of human papillomaviruses and eccrine ducts in palmoplantar epidermoid cysts. Br J Dermatol 1995;132:533-42.
49. de Villiers E-M, Hirsch-Behnam A, von Knebel Doeberitz C, et al. Two newly identified human papillomavirus types (HPV 40 and HPV 57) isolated from mucosal lesions. J Virol 1989;171:248-52.
50. Wu T-C, Trujillo J, Kahima H, et al. Association of human papillomavirus with nasal neoplasia. Lancet 1993;341: 522-41.
51. Ogura H, Fukushima K, Watanabe S. A high prevalence of human papillomavirus DNA in recurrent nasal papillomas. J Med Microbiol 1996;45:162-6.
52. Raspler DS, Jahn A, Pater A, et al. Isolatioin and characterization of papillomavirus DNA from nasal inverting (schneiderian) papillomas. Ann Otol Rhinol Laryngol 1987;96:170-3.
53. Broekaert D, Pattin C, Coucke P, et al. Keratinization of middle-ear cholesteatomas. I. A histochemical study of epidermal transglutaminase. Eur Arch Otorhinolaryngol 1990;247:312-7.
54. Van Blitterswijk CA, Grote JJ. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle-ear epithelium. Acta Otolaryngol 1988;105:529-32.
55. Chao W-Y, Huang C-C. An immunocytochemical study of cytokeratin expression in human middle-ear cholesteatoma. Arch Otorhinolaryngol 198;246:37-42.
56. Bergmann K, Hoppe F, He Y, et al. Human papillomavirus DNA in cholesteatomas. Int J Cancer 1994;59:463-6.
57. Shear M. Developmental odontogenic cysts. An update. J Oral Pathol Med 1994;23:1-11.
58. Ahlfors E, Larsson A, Sjörgen S. The odontogenic keratocyst: a benign cystic tumor? J Oral Maxillofac Surg 1984; 42:10-9.
59. Cox M, Eveson J, Scully C. Human papillomavirus type 16 DNA in an odontogenic keratocyst. J Oral Patol Med 1991; 20:143-5.
60. Kahn MA. Demonstration of human papillomavirus DNA in a peripheral ameloblastoma by in situ hybridization. Hum Pathol 1992;23:188-91.
61. Raubenheimer EJ, van Heerden WF, Noffke CE. Infrequent clinicopathological findings in 108 ameloblastomas. J Oral Pathol Med 1995;24:227-32.
62. Rider CA, Rupkalvis R, Miller AS, et al. Search for evidence of three viral agents in radicular (periapical) cysts with immunohistochemistry. Oral Surg Oral Med Oral Pathol Radiol Endod 1992;80:87-91.
63. de Villiers E-M, Frick M, Neumann T, et al. Is a papillomavirus infection an etiological factor in the development of odontogenic keratocysts? (submitted).
64. Orth G, Favre M, Croissant O. Characterization of a new type of human papillomavirus that causes skin warts. J Virol 1977;24:108-20.
65. Gissmann L, Pfister H, zur Hausen H. Human papillomaviruses (HPV): Characterization of four different isolates. Virology 1977;76:569-80.
66. Orth G, Jablonska S, Favre M, et al. Characterization of two new types of HPV from lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1978;75:1537-41.
67. Orth G, Jablonska S, Jarzabek-Chorzelska M, et al. Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979;39:1074-686.
68. Penn I. Post-transplant kidney cancers and skin cancers (including Kaposi's sarcoma). In: Schmähl D, Penn I, editors. Cancer in organ transplant recipients. Berlin: Springer-Verlag, 1991: 946-53.
69. Rüdlinger R, Smith IW, Bunney MH, et al. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986;115:681-92.
70. Van der Leest RJ, Zachow KR, Ostrow RS, et al. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1986;123:354-7.
71. Barr BB, Benton EC, McLaren K, et al. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989;1:124-9.
72. Kawashima M, Favre M, Obalek S, et al. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J Invest Dermatol 1990;95:537-42.
73. Obalek S, Favre M, Szymanczyk J, et al. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV 3 or HPV 3-related types in immunosuppressed patients. J Invest Dermatol 1992;98:936-41.
74. Trenfield K, Salmond CA, Pope JH, et al. Southern blot analysis of skin biopsies for human papillomavirus DNA: renal allograft recipients in south-eastern Queensland. Australas J Dermatol 1993;4:71-8.
75. Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993;72:2198-206.
76. Tieben LM, Berkhout RJM, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994;131: 226-30.
77. Stark LA, Arends MJ, McLaren KM, et al. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer 1994;69:222-9.
78. Shamanin V, Delius H, de Villiers E-M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994a;75:1149-56.
79. Berkhout RJM, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
80. Shamanin V, Glover M, Rausch C, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994b;54:4610-3.
81. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996;88:802-11.
82. de Jong-Tieben LM, Berkhout RJM, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995;105:367-71.
83. Lavergne D, Benton, C, de Villiers E-M. The multiplicity of papillomavirus types in nonmelanoma carcinomas of the skin in renal transplant recipients (submitted).